What is EdenRx and what does it offer?

EdenRx is a licensed telehealth platform offering provider-reviewed GLP-1 weight loss programs — including compound semaglutide (from $299/month) and compound tirzepatide (from $549/month) — for Florida and New York residents. No clinic visits required. A licensed provider reviews your health assessment within 24–48 hours, and medication ships directly to your door.

What are GLP-1 medications and how do they work?

GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that mimic a natural gut hormone to suppress appetite, slow gastric emptying, and regulate blood sugar. Semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are the most clinically proven GLP-1 medications, producing 15–22% average body weight loss in clinical trials.

How much does semaglutide cost in Florida?

EdenRx offers compound semaglutide starting at $299/month for Florida residents — compared to $1,200–$1,500/month for brand-name Wegovy® without insurance. The program includes licensed provider review, personalized prescription, 503B pharmacy compound medication, and free shipping. No insurance required. Only pay if approved.

How much does tirzepatide cost in New York?

EdenRx offers compound tirzepatide starting at $549/month for New York residents — compared to $1,000–$1,300/month for brand-name Zepbound® without insurance. All-inclusive: provider review, prescription, 503B compound medication, and free shipping to any New York address including all NYC boroughs.

Do I need to visit a clinic for GLP-1 treatment?

No. EdenRx is 100% online. Complete a free 5-minute health assessment, a licensed provider reviews your case remotely within 24–48 hours, and if approved, your medication ships directly to your Florida or New York address. No in-person visits or appointments required.

How much weight can I lose with semaglutide or tirzepatide?

Clinical trial data: semaglutide produces an average of 14.9% body weight loss over 68 weeks (STEP-1 trial, NEJM 2021). Tirzepatide produces up to 20.9% average body weight loss over 72 weeks (SURMOUNT-1 trial, NEJM 2022). For a 200-lb patient: ~30 lbs (semaglutide) to ~42 lbs (tirzepatide). Individual results vary.

What is compound semaglutide vs Ozempic or Wegovy?

Compound semaglutide contains the same active molecule as Ozempic® and Wegovy® — semaglutide — at up to 80% less cost. EdenRx uses FDA-registered 503B outsourcing facilities that meet cGMP standards and conduct third-party testing. Compound semaglutide: from $299/month vs. Wegovy® at $1,200–$1,500/month.

Who qualifies for GLP-1 weight loss treatment?

You may qualify if you have a BMI ≥ 30 (obesity), or a BMI ≥ 27 with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Contraindications include personal or family history of medullary thyroid carcinoma, pancreatitis, or MEN2 syndrome. Complete EdenRx's free assessment to find out if you qualify.

Is EdenRx available in New York City?

Yes. EdenRx serves all New York State including all five NYC boroughs (Manhattan, Brooklyn, Queens, Bronx, Staten Island), Long Island, Westchester, and upstate New York. Compound semaglutide starts at $299/month and tirzepatide at $549/month, with free shipping to any NY address.

What is the best Ozempic or Wegovy alternative?

Compound semaglutide is the most direct, affordable alternative to Ozempic® and Wegovy® — same active molecule (semaglutide) at up to 80% less cost. EdenRx offers compound semaglutide from $299/month vs. $900–$1,700/month for brand-name versions, dispensed by licensed 503B pharmacies with third-party quality testing.

Back to Education Center

Combination Guide

What Works Together — And What to Avoid

Understanding which therapies complement each other — and which combinations require caution or must be avoided — helps you have more informed conversations with your provider.

Important: This guide is educational only. All treatment combinations are determined by your licensed provider after reviewing your individual health history. Never start or stop therapies without provider guidance.

Synergistic Combinations

These pairings are commonly used together because their mechanisms complement each other.

GLP-1 + MICC Injection

Weight LossMetabolism

MICC (Methionine, Inositol, Choline, B12) supports liver fat metabolism and provides an energy boost — complementing the appetite reduction of GLP-1 therapy. Frequently prescribed together.

Very commonly combined by providers. Safe and synergistic.

GLP-1 + L-Carnitine Injection

Weight LossFat Metabolism

L-Carnitine shuttles fatty acids into the mitochondria for energy. When the body is actively burning fat on a GLP-1 program, L-Carnitine may support that metabolic process.

Frequently included in weight management protocols alongside GLP-1 therapy.

GLP-1 + B12 (Methylcobalamin)

Weight LossEnergy

Patients on GLP-1 programs often reduce caloric intake significantly. B12 supplementation helps maintain energy levels and supports neurological health during this process.

Safe and supportive — often included in comprehensive weight management programs.

BPC-157 + TB-500

RecoveryHealing

BPC-157 promotes tissue healing via growth factor and angiogenesis pathways. TB-500 (Thymosin Beta-4) supports cellular repair through actin regulation. Together, they address healing from complementary angles.

A widely used recovery stack. Protocols determined by your provider.

CJC-1295 + Ipamorelin

LongevityGH Support

CJC-1295 extends the GHRH signal, while Ipamorelin provides a complementary GHRP signal. Together they create a more sustained, physiological GH pulse than either alone. Designed to be used as a stack.

The combination is the standard approach — these are typically prescribed together.

NAD+ + Glutathione

LongevityAntioxidant

NAD+ supports cellular energy and DNA repair. Glutathione is the body's primary antioxidant. Together they support cellular health from both energy-production and oxidative-stress angles.

Popular longevity pairing. Provider determines administration method and timing.

GLP-1 + NAD+

Weight LossLongevity

NAD+ supports the metabolic and mitochondrial function that underpins energy balance. Some patients on GLP-1 programs find NAD+ helps maintain energy during dose escalation.

No known interactions. Discuss with your provider to ensure appropriateness for your situation.

Combinations Requiring Caution

These combinations aren't necessarily off-limits — but they require extra provider coordination and disclosure.

Two GLP-1 Medications Simultaneously

Do not combine semaglutide and tirzepatide — they act on overlapping pathways and combining them does not improve outcomes but increases side effect risk. Your provider will choose one.

Avoid without explicit provider direction

GLP-1 + Other Diabetes Medications (without supervision)

If you take insulin or other blood sugar medications, adding a GLP-1 agonist requires careful provider oversight to prevent hypoglycemia (dangerously low blood sugar). Always disclose all medications.

Requires provider coordination

Sermorelin + Active Cancer History

Growth hormone-related peptides like Sermorelin and CJC-1295/Ipamorelin may stimulate cell growth pathways. Patients with a history of hormone-sensitive cancers (e.g., prostate, breast) require extra screening.

Provider must review cancer history first

Multiple Growth Hormone Peptides (Sermorelin + CJC-1295 + Ipamorelin)

Stacking multiple GH-supporting peptides without provider guidance can oversaturate growth hormone pathways. Your provider determines the appropriate protocol.

Provider protocol required

NAD+ + Active Cancer Treatment

While NAD+ has many health benefits, its cell-energizing properties require provider clearance in patients undergoing active cancer treatment.

Requires oncologist clearance

Absolute Contraindications

These are firm exclusions — not gray areas. If any of these apply to you, be sure to disclose them during your medical intake.

Pregnant or breastfeeding patients

All GLP-1 medications, all peptide therapies (BPC-157, TB-500, Sermorelin, CJC-1295), and most injectable vitamins are contraindicated. Always inform your provider of pregnancy status.

Patients with personal or family history of MTC or MEN 2

GLP-1 receptor agonists (semaglutide, tirzepatide) are absolutely contraindicated. This is a firm exclusion — not a gray area.

Patients with active, untreated cancer

Growth hormone peptides (Sermorelin, CJC-1295, Ipamorelin) and immune-modulating compounds should not be started without oncologist clearance.

Patients with severe gastroparesis

GLP-1 medications significantly slow gastric emptying — combining them with severe gastroparesis can worsen symptoms. Disclose GI conditions during intake.